We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
Hybrid immunity will end pandemic
Are vaccines safe? Is booster dose required? Does COVID19 vaccine affect children? In... read more
Delegate visit from University of Manchester
We were pleased to host a delegation from University of Manchester led... read more
Wastewater surveillance reveals infection dynamics
Dr. Farah Ishtiaq, Principal scientist at Tata Institute for Genetics and Society... read more
COVID-19 is airborne; Masks still essential to avoid the spread of virus, Collaborative Study reveals
In a collaborative study, it is found that, novel Coronavirus is airborne... read more
TIGS and the Avestagenome Project® partner to advance research in Rare Genetic Disorders
The Avestagenome Project® International Pvt. Ltd. (AGENOME) & Avesthagen Limited, in partnership... read more
TIGS scientists present their work at International conference on Genetics and Genomics in Health and Diseases
Scientists from TIGS presented their work at the recently concluded 8th Annual... read more
PhD Admissions – List of shortlisted candidates
List of shortlisted candidates for TIGS PhD admissions (Jan 2023) via AcSIR... read more
On rising COVID-19 cases in several countries
There is need to exercise caution and follow COVID19 appropriate norms &... read more
SAGE Ambassadors TIGS visit
A day well spent with students! The senior and junior ambassadors of the... read more

